HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

bis-dehydroxycurcumin tert-butyl ester

structure in first source

Also Known As:

K2T23

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Diarylheptanoids: 471
        Curcumin: 10678
        bis-dehydroxycurcumin tert-butyl ester: 1
      - Benzene Derivatives: 17
        Phenols: 677
        Catechols: 121
        Curcumin: 10678
        bis-dehydroxycurcumin tert-butyl ester: 1
  - Acyclic Hydrocarbons
    - Alkanes: 241
      - Heptanes: 70
        Diarylheptanoids: 471
        Curcumin: 10678
        bis-dehydroxycurcumin tert-butyl ester: 1

Experts

1.	Ferrari, Erika: 1 article (01/2017)
2.	Maspero, Angelo: 1 article (01/2017)
3.	Nardo, Luca: 1 article (01/2017)
4.	Palmisano, Giovanni: 1 article (01/2017)
5.	Penoni, Andrea: 1 article (01/2017)
6.	Saladini, Monica: 1 article (01/2017)

Related Diseases

1.	Neoplasms (Cancer) 01/01/2017 - "This property should endow K2T23 with superior excited-state stability when excited in the UVB band, i.e., in correspondence of the diketo conformers absorption peaks, making this compound an interesting candidate for topical photodynamic therapy of, e.g., skin tumors or oral infections. "
2.	Infections 01/01/2017 - "This property should endow K2T23 with superior excited-state stability when excited in the UVB band, i.e., in correspondence of the diketo conformers absorption peaks, making this compound an interesting candidate for topical photodynamic therapy of, e.g., skin tumors or oral infections. "

Related Therapies and Procedures

1.	Photochemotherapy (Photodynamic Therapy)